Sort
21,453 grants matching “tuberculosis”
Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB
$1,001,605Michael Levin · Imperial College Of Science, Technology And Medicine · R01 · FY2017 · AI
MDR-TB Drugs: Targeting Cell Wall Synthetic Enzymes
$1,000,797Colorado State University-Fort Collins · P01 · FY2004 · AI
Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB
$1,000,208Michael Levin · Imperial College Of Science, Technology And Medicine · R01 · FY2018 · AI
Extended follow-up of randomized participants in the INSIGHT START trial
$1,000,000Birgit Grund · University Of Minnesota · U01 · FY2024 · AI
EXTRAMURAL RES FACILITIES: TUBERCULOSIS AND GENETICS
$1,000,000Albert Einstein Col Of Med Yeshiva Univ · C06 · FY2005 · RR
Collaborative African Genomics Network (CAfGEN)
$1,000,000Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2018 · AI
Collaborative African Genomics Network (CAFGEN)
$1,000,000Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2016 · AI
Early and accurate diagnosis of pulmonary and extrapulmonary tuberculosis in all patient groups using a circulating pathogen-derived antigen
$1,000,000Thomas W Tombler · Nanopin Technologies, Inc. · R44 · FY2021 · AI
Recombinant yeast vaccines for sensitive and drug-resistant M. tuberculosis
$1,000,000Timothy Rodell · Globeimmune, Inc. · R01 · FY2013 · AI
Regional Prospective Observational Research in Tuberculosis (RePORT) â Brazil Network
$1,000,000Timothy R Sterling · Vanderbilt University Medical Center · U01 · FY2023 · AI
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM
$1,000,000Weill Medical College Of Cornell Univ · D43 · FY2003 · TW
ENHANCING MODELS OF HIV, VIRAL HEPATITIS, STIs, AND TUBERCULOSIS TO INFORM AND IMPROVE PUBLIC HEALTH IMPACT
$1,000,000Patrick Sullivan · Emory University · U38 · FY2014 · PS
Recombinant yeast vaccines for sensitive and drug-resistant M. tuberculosis
$1,000,000Timothy Rodell · Globeimmune, Inc. · R01 · FY2014 · AI
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$1,000,000Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2019 · AI
EXTRAMURAL RES FACIL CONST: TB
$1,000,000University Of Puerto Rico Rio Piedras · C06 · FY2002 · RR
A new class of broad-spectrum antibacterials for treating MDR infections
$1,000,000Charles Testa · Curza Inc · R44 · FY2021 · AI
3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology
$1,000,000Jay Wyatt Warrick · Salus Discovery, Llc · R44 · FY2025 · AI
Collaborative African Genomics Network (CAfGEN)
$1,000,000Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2021 · AI
Collaborative African Genomics Network (CAfGEN)
$1,000,000Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2019 · AI
Development of a Dual-Targeting ClpP Activating Antibiotic
$1,000,000Michael Lafleur · Arietis · R44 · FY2025 · AI
Nebulized ALX1 as a Treatment for Difficult Non-tuberculous Mycobacterial Lung Infections
$1,000,000Nathan Allan Stasko · Vast Therapeutics, Inc. · R44 · FY2025 · AI
HPMI: Host Pathogen Mapping Initiative
$1,000,000Nevan J Krogan · University Of California, San Francisco · U19 · FY2021 · AI
VACCINE AND EVALUTION TREATMENT UNITS
$1,000,000Mark Joseph Mulligan · Emory University · N01 · FY2011 · AI
Bloodstream infection detection directly on whole blood
$1,000,000Alfredo Andres Celedon · Scanogen, Inc. · R44 · FY2020 · AI
DAIDS RePORT India Consortium
$1,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI